Low-Dose Aripiprazole is a Promising Drug for Long COVID Treatment: A Retrospective Observational Study
Retrospective observational study investigating the efficacy of low-dose aripiprazole in treating Long COVID symptoms.
Read full paperPeer-reviewed research in clinical AI, sleep medicine, and digital health.
View Full Profile on Google ScholarRecent work and key contributions
Retrospective observational study investigating the efficacy of low-dose aripiprazole in treating Long COVID symptoms.
Read full paperInvestigation into the relationship between cortisol levels and Long COVID diagnosis and prognosis.
Read full paperComprehensive assessment of sleep disturbances in Long COVID patients using standardized questionnaires.
Read full paperStudy on the impact of sleep education programs on university students' sleep habits and knowledge.
Read full paperRefining scoring algorithms for the Stanford Cataplexy Questionnaire to improve narcolepsy diagnosis accuracy.
Read full paperUsing wrist accelerometer data to detect early gait changes associated with Parkinson's Disease before clinical diagnosis.
Read full paperAnalysis of how adults with Restless Legs Syndrome perceive and respond to exercise interventions.
Read full paperFor a comprehensive list of all publications, citations, and collaborations, visit my Google Scholar profile.
Google Scholar Profile